These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6595809)

  • 21. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of chronic granulocytic leukemia.
    Can Med Assoc J; 1968 Jul; 99(3):129-30. PubMed ID: 4877613
    [No Abstract]   [Full Text] [Related]  

  • 23. Rotational therapy with a colchicine analog in chronic granulocytic leukemia.
    Stolinsky DC; Weiner JM; Bateman JR
    Oncology; 1980; 37(1):62-3. PubMed ID: 6927936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trial of treatment of chronic myeloid leukemias with mitomycin C].
    Olmer J; Gabriel B
    Presse Med (1893); 1971 Oct; 79(44):1965-7. PubMed ID: 5287031
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
    Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination chemotherapy for chronic granulocytic leukaemia.
    Allan NC; Duvall E; Stockdill G
    Lancet; 1978 Sep; 2(8088):523. PubMed ID: 79887
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.
    Ferrara F; Palmieri S; Annunziata M; Viola A; Pocali B; Califano C; D'Arco AM; Mele G
    Bone Marrow Transplant; 2004 Oct; 34(7):573-6. PubMed ID: 15258559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term survival in chronic granulocytic leukemia].
    Coliţă A; Butoianu E; Nicoară S; Gociu M; Munteanu N; Hossu T; Ciocoiu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):247-52. PubMed ID: 6140719
    [No Abstract]   [Full Text] [Related]  

  • 32. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
    Chrobák L; Radochová D; Chrobáková H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(5):565-70. PubMed ID: 5267593
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J; Muratore R; Gabriel B; Canu AM
    Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481
    [No Abstract]   [Full Text] [Related]  

  • 34. Granulocytic leukemia in pregnancy.
    Kadowaki J; Moghissi KS; Loomus GN
    Mich Med; 1970 Apr; 69(7):297-9. PubMed ID: 5270610
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
    Madden T; de Lima M; Thapar N; Nguyen J; Roberson S; Couriel D; Pierre B; Shpall EJ; Jones RB; Champlin RE; Andersson BS
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):56-64. PubMed ID: 17222753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochemical evaluation of cytostatic drugs action in chronic granulocytic and lymphatic leukemia.
    Orzechowska-Juzwenko K
    Pol J Pharmacol Pharm; 1980; 32(3):271-80. PubMed ID: 6944693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
    Klimova NF; Cherntsova TA; Protasova TG
    Sov Med; 1967 Dec; 30(12):67-71. PubMed ID: 5250006
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic myeloid leukemia with a long survival time].
    de Vries SI
    Ned Tijdschr Geneeskd; 1969 Jul; 113(28):1225-6. PubMed ID: 5255682
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
    Gollerkeri MP; Shah GB
    Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amenorrhea in the course of chronic myelotic leukemia treated busulfan].
    Chmielewski T; Lemanczyk A
    Pol Tyg Lek; 1966 Jan; 21(2):62-3. PubMed ID: 5217377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.